Anna U. Loengard - 06 Jan 2026 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reporting relationship: Director
Issuer ticker: CLOV
Reported as of: 06 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jan 2026, 16:06:44 UTC
Prior SEC filing: 14 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard

Key filing fact

Anna U. Loengard filed Form 4 for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) on 08 Jan 2026.

Key facts

This page summarizes Anna U. Loengard's Form 4 filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Jan 2026, 16:06.

Change

Previous filing in this sequence was filed on 14 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001952723 Primary reporting owner

Loengard Anna U

Relationship: Director
Address: C/O CLOVER HEALTH INVESTMENTS, CORP., NOT APPLICABLE, WILMINGTON
Signature: /s/Peter J. Rivas as attorney-in-fact for Anna U. Loengard
Signature date: 08 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLOV transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +79,365
Change %: +18%
Price: $0.000000
Shares after: 527,456
Date: 06 Jan 2026
Ownership: Direct
Footnotes: F1

CLOV holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,600
Date: 06 Jan 2026
Ownership: By Son IRA
Footnotes: F2

CLOV holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 29,610
Date: 06 Jan 2026
Ownership: By Daughter IRA
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.

Footnote F2

Held in a custodial IRA for the benefit of Reporting Person's son, for which the Reporting Person serves as custodian.

Footnote F3

Held in a custodial IRA for the benefit of Reporting Person's daughter, for which the Reporting Person serves as custodian.